Compounds > pioglitazone
Page last updated: 2024-08-16

pioglitazone and methionine

pioglitazone has been researched along with methionine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Game, BA; Huang, Y; Lopes-Virella, MF; Xu, M1
Agostini, M; Chatterjee, VK; Garnes, KT; Gurnell, M; Levinson, SH; O'Rahilly, S; Rajanayagam, O; Savage, DB; Schwabe, JW; Smith, AG; Willson, TM; Wood, EM; Xu, HE1
Akahori, H; Kaneko, S; Kita, Y; Kurita, S; Matsuzawa, N; Misu, H; Nakanuma, Y; Ota, T; Sakurai, M; Takamura, T; Uno, M; Zen, Y1
Abarca-Quinones, J; Brichard, S; Da Silva Morais, A; Guigas, B; Hue, L; Lebrun, V; Leclercq, IA; Viollet, B1
Du, J; Kong, L; Nan, Y; Niu, X; Wang, R; Zhang, Y; Zhao, S1
Gao, CQ; Jin, CL; Li, HC; Wang, Q; Wang, XQ; Xu, YL; Yan, HC; Zhang, ZM1
Gao, CQ; Jin, CL; Tan, HZ; Wang, XQ; Yan, HC; Zeng, HR1
Al-Azzam, SI; Alfaqih, M; Alrabadi, N; Alzoubi, KH; Khabour, OF; Mhaidat, NM; Tashtoush, M1

Reviews

1 review(s) available for pioglitazone and methionine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for pioglitazone and methionine

ArticleYear
Regulation of MMP-1 expression in vascular endothelial cells by insulin sensitizing thiazolidinediones.
    Atherosclerosis, 2003, Volume: 169, Issue:2

    Topics: Cells, Cultured; Chromans; Cysteine; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Eukaryotic Initiation Factors; Humans; Hypoglycemic Agents; Immunoblotting; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Methionine; Pioglitazone; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Troglitazone; Umbilical Veins

2003
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma.
    Endocrinology, 2004, Volume: 145, Issue:4

    Topics: Amino Acid Sequence; Cell Line; Gene Expression; Genes, Dominant; Humans; Leucine; Ligands; Methionine; Models, Structural; Molecular Sequence Data; Monocytes; Mutation; Oxazoles; Pioglitazone; Proline; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transfection; Tyrosine; Valine

2004
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Gastroenterology, 2007, Volume: 132, Issue:1

    Topics: Animal Feed; Animals; Choline; Collagen Type I; Collagen Type I, alpha 1 Chain; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Fatty Liver; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Methionine; Obesity; Pioglitazone; Plasminogen Activator Inhibitor 1; PPAR gamma; Rats; Rats, Inbred OLETF; Rats, Long-Evans; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones; Transforming Growth Factor beta; Up-Regulation

2007
Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.
    Journal of hepatology, 2009, Volume: 50, Issue:3

    Topics: Adiponectin; AMP-Activated Protein Kinase Kinases; Animals; Choline Deficiency; DNA Primers; Fatty Liver; Female; Inflammation; Liver; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Pioglitazone; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones

2009
TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Animals; Chemokines; Choline; Diet; Down-Regulation; Fibrosis; Inflammation; Liver; Liver Cirrhosis; Male; Methionine; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Pioglitazone; PPAR gamma; Protective Agents; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4

2016
Dietary Supplementation with Pioglitazone Hydrochloride and Chromium Methionine Improves Growth Performance, Meat Quality, and Antioxidant Ability in Finishing Pigs.
    Journal of agricultural and food chemistry, 2018, May-02, Volume: 66, Issue:17

    Topics: Adipose Tissue; Animal Feed; Animals; Antioxidants; Body Composition; Chromium; Diet; Dietary Supplements; Drug Synergism; Fatty Acids; Female; Lipoproteins, HDL; Male; Meat; Methionine; Muscle, Skeletal; Pioglitazone; Sus scrofa; Thiazolidinediones

2018
Dietary supplementation with pioglitazone hydrochloride and chromium methionine manipulates lipid metabolism with related genes to improve the intramuscular fat and fatty acid profile of yellow-feathered chickens.
    Journal of the science of food and agriculture, 2020, Volume: 100, Issue:3

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Chickens; Chromium; Cooking; Diet; Dietary Supplements; Fatty Acids; Female; Lipid Metabolism; Meat; Methionine; Muscle, Skeletal; Pioglitazone

2020
The Protective Effects of Pioglitazone Against Cognitive Impairment Caused by L-methionine Administration in a Rat Model.
    CNS & neurological disorders drug targets, 2022, Volume: 21, Issue:1

    Topics: Animals; Antioxidants; Cognitive Dysfunction; Hippocampus; Hypoglycemic Agents; Male; Maze Learning; Memory Disorders; Methionine; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar

2022